Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management

[1]  Young Tae Kim,et al.  Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma , 2015, PloS one.

[2]  Saptarshi Ghosh,et al.  Osseous Metastases in Gynaecological Epithelial Malignancies: A Retrospective Institutional Study and Review of Literature. , 2015, Journal of clinical and diagnostic research : JCDR.

[3]  T. Cunha,et al.  Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences. , 2015, Diagnostic and interventional radiology.

[4]  N. Bertheuil,et al.  Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Kumiko Goto,et al.  Prevalence, Classification, and Risk Factors for Postoperative Lower Extremity Lymphedema in Women With Gynecologic Malignancies: A Retrospective Study , 2015, International Journal of Gynecologic Cancer.

[6]  Kathleen R. Cho,et al.  Cervical cancer, version 2.2015: Featured updates to the NCCN guidelines featured updates to the NCCN guidelines , 2015 .

[7]  A. Shinagare,et al.  Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[9]  J. Robbins,et al.  PET/CT and MRI in the imaging assessment of cervical cancer , 2015, Abdominal Imaging.

[10]  Young Tae Kim,et al.  A Multicenter Study of the Importance of Systemic Chemotherapy for Patients with Small-Cell Neuroendocrine Carcinoma of the Uterine Cervix , 2014, Gynecologic and Obstetric Investigation.

[11]  K. Sugimura,et al.  Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRI. , 2014, Clinical imaging.

[12]  I. Chitapanarux,et al.  Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma , 2014, OncoTargets and therapy.

[13]  Young Seok Kim,et al.  A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: a Korean radiation oncology group study (KROG 12-08). , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  B. Monk,et al.  Improved survival with bevacizumab in advanced cervical cancer. , 2014, The New England journal of medicine.

[15]  A. Shinagare,et al.  Liver metastases in the era of molecular targeted therapy: new faces of treatment response. , 2013, AJR. American journal of roentgenology.

[16]  R. Sasaki,et al.  Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factors , 2013, Journal of radiation research.

[17]  H. Hricak,et al.  Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration , 2013, European Radiology.

[18]  M. Folkert,et al.  Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation. , 2013, Gynecologic oncology.

[19]  A. Shinagare,et al.  Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. , 2012, AJR. American journal of roentgenology.

[20]  J. Jagannathan,et al.  Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know. , 2012, AJR. American journal of roentgenology.

[21]  J. W. Kim,et al.  Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Pötter,et al.  Nomogram prediction for overall survival of patients diagnosed with cervical cancer , 2012, British Journal of Cancer.

[23]  Jason D. Wright,et al.  Prognostic significance of adenocarcinoma histology in women with cervical cancer. , 2012, Gynecologic oncology.

[24]  B. Goff,et al.  Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. , 2011, American journal of obstetrics and gynecology.

[25]  F. Gleeson,et al.  18F-FDG PET/CT of cervical carcinoma. , 2011, AJR. American journal of roentgenology.

[26]  Mi-Sook Kim,et al.  Nomogram prediction of overall survival after curative irradiation for uterine cervical cancer. , 2011, International journal of radiation oncology, biology, physics.

[27]  C. Y. Park,et al.  Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment , 2011, Nuclear medicine and molecular imaging.

[28]  E. Sala,et al.  The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. , 2010, European journal of radiology.

[29]  J. Chan,et al.  Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. , 2010, American journal of obstetrics and gynecology.

[30]  Y. Song,et al.  Postoperative Nomogram Predicting Risk of Recurrence After Radical Hysterectomy for Early-Stage Cervical Cancer , 2010, International Journal of Gynecologic Cancer.

[31]  B. Monk,et al.  Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  K. Chao,et al.  Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. , 2010, American journal of obstetrics and gynecology.

[33]  A. Tinker,et al.  A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184. , 2010, Gynecologic oncology.

[34]  L. Stalpers,et al.  Can We Predict Vesicovaginal or Rectovaginal Fistula Formation in Patients With Stage IVA Cervical Cancer? , 2009, International Journal of Gynecologic Cancer.

[35]  E. Mittra,et al.  Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  O. Hoekstra,et al.  Clarifying the Diagnosis of Clinically Suspected Recurrence of Cervical Cancer: Impact of 18F-FDG PET , 2008, Journal of Nuclear Medicine.

[37]  S. Choi,et al.  Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI. , 2008, AJR. American journal of roentgenology.

[38]  T. Yen,et al.  Detection of lymph node metastasis in cervical and uterine cancers by diffusion‐weighted magnetic resonance imaging at 3T , 2008, Journal of magnetic resonance imaging : JMRI.

[39]  D. Gaffney,et al.  Incidence, Mortality, and Prognostic Factors of Small Cell Carcinoma of the Cervix , 2008, Obstetrics and gynecology.

[40]  N. Mahajan.  Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma. , 2008, Gynecologic oncology.

[41]  A. Gadducci,et al.  Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. , 2007, Gynecologic oncology.

[42]  R. Barakat,et al.  Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery , 2007, International Journal of Gynecologic Cancer.

[43]  Miao-Fen Chen,et al.  Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[44]  Indira Poola,et al.  Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues , 2007, BMC Cancer.

[45]  E. Tuller,et al.  Small cell carcinoma of the female genital tract. , 2007, Seminars in oncology.

[46]  Mitchell D Schnall,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessing Tumor Vascularity and Vascular Effects of Targeted Therapies in Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[47]  P. Pairolero,et al.  Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. , 2006, The Annals of thoracic surgery.

[48]  Seok-ki Kim,et al.  Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma , 2006, Cancer.

[49]  M. Harisinghani,et al.  Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Chun-Chieh Wang,et al.  Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[51]  D. Cella,et al.  Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  K. Shiromizu,et al.  Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis. , 2004, The Annals of thoracic surgery.

[53]  Patrick M M Bossuyt,et al.  Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.

[54]  H. Sung,et al.  Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. , 2003, Obstetrics and gynecology.

[55]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[56]  J. Carlson,et al.  Adenosquamous histology predicts a poor outcome for patients with advanced‐stage, but not early‐stage, cervical carcinoma , 2003, Cancer.

[57]  M. Friedlander,et al.  Guidelines for the treatment of recurrent and metastatic cervical cancer. , 2002, The oncologist.

[58]  J. Wharton,et al.  Posttherapy surveillance of women with cervical cancer: an outcomes analysis. , 2000, Gynecologic oncology.

[59]  C. Choi,et al.  Diagnosis of Recurrent Uterine Cervical Cancer: Computed Tomography versus Positron Emission Tomography , 2000, Korean journal of radiology.

[60]  A. Martinez,et al.  Pelvic insufficiency fractures in patients with pelvic irradiation. , 1999, International journal of radiation oncology, biology, physics.

[61]  V. Rantanen,et al.  PAP smear after radiation therapy for cervical carcinoma. , 1997, Anticancer research.

[62]  K. Kinkel,et al.  Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. , 1997, Radiology.

[63]  H. Averette,et al.  An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. , 1996, Gynecologic oncology.

[64]  E. Rofstad,et al.  Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging. , 1996, AJR. American journal of roentgenology.

[65]  M. Knopp,et al.  Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. , 1996, AJR. American journal of roentgenology.

[66]  E. Partridge,et al.  Squamous Cell Carcinoma of the Uterine Cervix: Patterns of Thoracic Metastases , 1995, Investigative radiology.

[67]  T. Burke,et al.  Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. , 1995, Gynecologic oncology.

[68]  H. Hricak,et al.  Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. , 1993, Radiology.

[69]  G. Morley,et al.  A comparison of adenocarcinoma and squamous cell carcinoma of the cervix , 1991, Obstetrics and gynecology.

[70]  J. Roberts,et al.  Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix , 1989, Gynecologic oncology.

[71]  D. Cosgrove,et al.  The value of CT in the diagnosis of recurrent carcinoma of the cervix. , 1988, Clinical radiology.

[72]  L Axel,et al.  Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. , 1988, Radiology.

[73]  R. Park,et al.  Clinical Patterns of Tumor Recurrence After Radical Hysterectomy in Stage IB Cervical Carcinoma , 1987, Obstetrics and gynecology.

[74]  N. Day,et al.  Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. , 1985, Journal of the National Cancer Institute.

[75]  J. van Nagell,et al.  Therapeutic implications of patterns of recurrence in cancer of the uterine cervix , 1979, Cancer.

[76]  M. Melamed,et al.  Radiation-induced soft-tissue and bone sarcoma. , 1978, Radiology.

[77]  J. Johnsson.  Squamous cell carcinoma of the uterine cervix. , 1977, Acta radiologica: therapy, physics, biology.

[78]  M. Deutsch,et al.  Radiotherapy for carcinoma of the cervix recurrent after surgery , 1974, Cancer.

[79]  E S Hafez,et al.  Uterine cervix. , 1969, Science.

[80]  A. G. Foraker,et al.  Squamous-cell carcinoma of the uterine cervix; a histochemical review. , 1958, American journal of obstetrics and gynecology.

[81]  F. Landoni,et al.  Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[82]  K. Tewari,et al.  Changing paradigms in the systemic treatment of advanced cervical cancer. , 2016, American journal of obstetrics and gynecology.

[83]  R Kevin Reynolds,et al.  Cervical Cancer, Version 2.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[84]  P. Escobar,et al.  Small cell carcinoma of the uterine cervix: a case report and literature review. , 2015, Boletin de la Asociacion Medica de Puerto Rico.

[85]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[86]  N. Rofsky,et al.  Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. , 2010, Radiology.

[87]  F. Fazio,et al.  Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. , 2006, Radiology.

[88]  R. Coleman,et al.  Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[89]  R. Coleman,et al.  Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer , 2004 .

[90]  D. González González,et al.  Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. , 1998, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[91]  C. Spritzer,et al.  Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. , 1995, Radiology.

[92]  J. Lee,et al.  MR appearance of the normal and abnormal vagina after hysterectomy. , 1992, AJR. American journal of roentgenology.

[93]  J. Walsh,et al.  Recurrent carcinoma of the cervix: CT diagnosis. , 1981, AJR. American journal of roentgenology.

[94]  E. Manes,et al.  [Radiation-induced sarcoma]. , 1975, La Chirurgia degli organi di movimento.